James R. Heath PhD is President and Professor of the Institute for Systems Biology in Seattle, and Professor of Molecular and Medical Pharmacology at UCLA. He has directed the National Cancer Institute-funded NSB Cancer Center since 2005. He has also founded or cofounded several biotech companies. Recently, he was the lead author of a large study that used a range of advanced technologies to characterize biological factors that predispose to development of LongCovid